Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

P. Simioni, V. Pengo, P. Prandoni
{"title":"Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history","authors":"P. Simioni, V. Pengo, P. Prandoni","doi":"10.4081/btvb.2022.52","DOIUrl":null,"url":null,"abstract":"The year 1222 has traditionally been accepted as the University of Padua’s founding date. The University of Padua is a prestigious center for learning and research, and over the centuries, it has produced luminaries in the most significant disciplines, including medicine, law, philosophy, theology, literature, engineering, astronomy, physics, politics, and religion. The Studium of the teaching of Medicine began around 1250 with the establishment of the Collegium of Medical and Arts Doctors. The history of Medicine at Padua University is extraordinarily rich and counts on the contribution of masters such as Vesalius, Falloppia, Girolamo Fabrici d’Acquapendente, William Harvey, Vallisneri, Ramazzini, Morgagni and many others including Galileo Galilei himself. This year marks the 800th anniversary of the University of Padua, and to commemorate this historic event, the Editor has asked the three of us to summarize the university’s most significant contributions to the fields of hemostasis and thrombosis over the past eight decades. Among all, it should be mentioned the relevant contribution of Prof. Antonio Girolami, who was the founder of the group of Thrombosis and Hemostasis in Padua and one of the Italian and international leaders in the field of the diagnosis and treatment of congenital bleeding disorders. However, due to the large number of outstanding scientists and significant research conducted in these fields at Padua University, it was extremely difficult for us to provide a concise summary of the university’s numerous contributions. Eventually, we concluded that it would be more useful to share with the Readers the experiences we have had over the past several decades, focusing on specific aspects of our research, work, and life at Padua University, and attempting to highlight the aspects that we believe have contributed most to the advancement of knowledge in the fields of thrombosis and hemostasis. Therefore, three topics have been selected and presented separately in a narrative format as pieces of our lives and of the history of our university.","PeriodicalId":186928,"journal":{"name":"Bleeding, Thrombosis, and Vascular Biology","volume":"54 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bleeding, Thrombosis, and Vascular Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/btvb.2022.52","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The year 1222 has traditionally been accepted as the University of Padua’s founding date. The University of Padua is a prestigious center for learning and research, and over the centuries, it has produced luminaries in the most significant disciplines, including medicine, law, philosophy, theology, literature, engineering, astronomy, physics, politics, and religion. The Studium of the teaching of Medicine began around 1250 with the establishment of the Collegium of Medical and Arts Doctors. The history of Medicine at Padua University is extraordinarily rich and counts on the contribution of masters such as Vesalius, Falloppia, Girolamo Fabrici d’Acquapendente, William Harvey, Vallisneri, Ramazzini, Morgagni and many others including Galileo Galilei himself. This year marks the 800th anniversary of the University of Padua, and to commemorate this historic event, the Editor has asked the three of us to summarize the university’s most significant contributions to the fields of hemostasis and thrombosis over the past eight decades. Among all, it should be mentioned the relevant contribution of Prof. Antonio Girolami, who was the founder of the group of Thrombosis and Hemostasis in Padua and one of the Italian and international leaders in the field of the diagnosis and treatment of congenital bleeding disorders. However, due to the large number of outstanding scientists and significant research conducted in these fields at Padua University, it was extremely difficult for us to provide a concise summary of the university’s numerous contributions. Eventually, we concluded that it would be more useful to share with the Readers the experiences we have had over the past several decades, focusing on specific aspects of our research, work, and life at Padua University, and attempting to highlight the aspects that we believe have contributed most to the advancement of knowledge in the fields of thrombosis and hemostasis. Therefore, three topics have been selected and presented separately in a narrative format as pieces of our lives and of the history of our university.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
帕多瓦大学的血栓和止血术:在其800年历史之际的重新评估
1222年被公认为帕多瓦大学的传统建校日期。帕多瓦大学是一个著名的学习和研究中心,几个世纪以来,它在最重要的学科中产生了杰出的人物,包括医学、法律、哲学、神学、文学、工程、天文学、物理学、政治和宗教。大约在1250年,随着医学和艺术医生学院的建立,医学教学的工作室开始了。帕多瓦大学的医学史非常丰富,有维萨里乌斯、法洛皮亚、吉罗拉莫·法布里西·德·acquapendente、威廉·哈维、瓦利斯内里、拉马齐尼、莫加尼以及包括伽利略·伽利莱在内的许多其他大师的贡献。今年是帕多瓦大学建校800周年,为了纪念这一历史性事件,编辑邀请我们三人总结一下帕多瓦大学在过去80年里对止血和血栓领域最重要的贡献。其中,应该提到Antonio Girolami教授的相关贡献,他是帕多瓦血栓和止血组的创始人,也是先天性出血性疾病诊断和治疗领域的意大利和国际领导者之一。然而,由于帕多瓦大学在这些领域有大量杰出的科学家和重要的研究,我们很难对该大学的众多贡献进行简要的总结。最后,我们得出结论,与读者分享我们过去几十年的经验会更有用,重点是我们在帕多瓦大学的研究、工作和生活的具体方面,并试图突出我们认为对血栓和止血领域的知识进步贡献最大的方面。因此,我们选择了三个主题,并以叙事的形式分别呈现,作为我们生活和我们大学历史的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
In memoriam of Professor Bruno Bizzi (1927-2023) Polycythemia vera and management of the thrombotic risk: an update Importance of assessment of carotid plaques in the managementof acute ischemic stroke: floating intracarotid plaque Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition? Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1